What's your research worth?

British grant applicants will have to demonstrate the economic or social impact of their research, according to new funding rules rolled out by linkurl:Research Councils UK;http://www.rcuk.ac.uk/ (RCUK), the umbrella body for all of Britain's seven research councils. The "impact summary," which requires grant seekers to answer questions about the wider benefits of their research, was implemented today (Jan. 15) by the Biotechnology and Biological Sciences Research Council (BBSRC). Other funding

Written byElie Dolgin
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
British grant applicants will have to demonstrate the economic or social impact of their research, according to new funding rules rolled out by linkurl:Research Councils UK;http://www.rcuk.ac.uk/ (RCUK), the umbrella body for all of Britain's seven research councils. The "impact summary," which requires grant seekers to answer questions about the wider benefits of their research, was implemented today (Jan. 15) by the Biotechnology and Biological Sciences Research Council (BBSRC). Other funding bodies, including the Natural Environment Research Council (NERC), will follow suit in the coming months. The Medical Research Council (MRC), which operates under a different system, was unaffected by the decision.
"The change is to underline our 'excellence with impact' agenda," Chloë Somers, a media spokesperson with RCUK, told __The Scientist__. "We recognize the fact that researchers are already doing this but we want to make it easier for them." Critics, however, argue that the initiative pushes academic research closer to a corporate model, and that it could hurt blue-skies research initiatives. "To try and make predictions about the impact of a piece of research in the early stages is going to be extremely difficult," Nick Dusic, director of the linkurl:Campaign for Science and Engineering,;http://www.savebritishscience.org.uk/ told __The Scientist__. "Most researchers won't know what the societal or economic benefit will be until after [the research] has been done, and there could be unforeseeable benefits that weren't anticipated when the research project started." Philip Esler, chief executive of the linkurl:UK Arts and Humanities Research Council;http://www.ahrc.ac.uk/ and the leader of RCUK's policy on economic impact, disagreed. "We're not trying to in any way divert researchers from doing excellent research," he told the__ linkurl:Times Higher Education Supplement.;http://www.timeshighereducation.co.uk/story.asp?sectioncode=26&storycode=404997&c=1 __"We want them to continue to do that, and we want to encourage them to produce other benefits. We believe they will have more fulfilling careers if they do." "Excellent research without obvious or immediate impact will continue to be funded by the Research Councils and will not be disadvantaged within the assessment process," the RCUK wrote in a statement.
**__Related stories:__***linkurl:Sparring over UK funding plan;http://www.the-scientist.com/news/display/24225/
[2nd August 2006]*linkurl:UK knowledge transfer found lacking;http://www.the-scientist.com/news/display/23255/
[29th March 2006]*linkurl:New umbrella body for British biology;http://www.the-scientist.com/news/display/21582/
[11th September 2003]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies